Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 7/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.63 |
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | AR | P10275 | 5/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.46 |
| ▸ | TUBB | P07437 | 1/20 | 0.46 |
| ▸ | YES1 | P07947 | 1/20 | 0.46 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.46 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.46 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.46 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.46 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL349721 | 0.84 | CYP19A1 (0.62) | CYP19A1ARCYP3A4MAOAMAOB | |
| SCHEMBL1508800 | 0.81 | CYP19A1 (0.64) | CYP19A1ARCYP3A4MAOAMAOB | |
| SCHEMBL28030288 | 0.81 | CYP19A1 (0.72) | CYP19A1PTGS1PTGS2TYRAR | |
| SCHEMBL27860085 | 0.81 | CYP19A1 (0.51) | CYP19A1ARCYP3A4TUBB4ATUBB | |
| SCHEMBL28035030 | 0.79 | AR (0.74) | CYP19A1PTGS1PTGS2TYRAR | |
| SCHEMBL2781916 | 0.79 | MAPT (0.71) | CYP19A1PTGS2CYP3A4TUBB4ATUBB | |
| SCHEMBL15544304 | 0.78 | MAPT (0.55) | CYP19A1ARCYP3A4TUBB4ATUBB | |
| Steppogenin SCHEMBL6822729 | 0.77 | CYP19A1 (1.00) | CYP19A1PTGS1PTGS2TYRCYP3A4 | |
| Steppogenin SCHEMBL29649083 | 0.77 | CYP19A1 (1.00) | CYP19A1PTGS1PTGS2TYRCYP3A4 | |
| Steppogenin SCHEMBL677660 | 0.77 | CYP19A1 (1.00) | CYP19A1PTGS1PTGS2TYRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140018552-A1 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | DONG WHA PHARM. CO., LTD. (KR) | 2014-01-16 | — | — | US | claimed |
| US-6737439-B2 | ACTIVE CANCER CHEMOPREVENTATIVE AND TREATING AGENTS IN MAMMALS, INCLUDING HUMANS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2004-05-18 | — | — | US | claimed |
| US-20030125377-A1 | Aromatase inhibitors from Broussonetia papyrifera | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS THE | 2003-07-03 | — | — | US | claimed |
| US-20190142940-A1 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2019-05-16 | — | — | US | disclosed |
| US-9744237-B2 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2017-08-29 | — | — | US | disclosed |
| WO-2014168458-A1 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | DONG WHA PHARM. CO., LTD. (KR) | 2014-10-16 | — | — | WO | disclosed |
| EP-2691092-A2 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | Dong Wha Pharm. Co., Ltd. (KR) | 2014-02-05 | — | — | EP | disclosed |
| EP-2691092-A2 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | Dong Wha Pharm. Co., Ltd. (KR) | 2014-02-05 | — | — | EP | disclosed |
| US-20140018552-A1 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | DONG WHA PHARM. CO., LTD. (KR) | 2014-01-16 | — | — | US | disclosed |
| US-20140018552-A1 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | DONG WHA PHARM. CO., LTD. (KR) | 2014-01-16 | — | — | US | disclosed |
| CN-103476408-A | Application of compound separated from cortex mori | DONG WHA PHARM CO LTD | 2013-12-25 | — | — | CN | disclosed |
| WO-2012134126-A2 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | DONG WHA PHARM. CO., LTD. (KR) | 2012-10-04 | — | — | WO | disclosed |
| US-20120207809-A1 | Method and system for effecting changes in pigmented tissue | MOAZED KAMBIZ THOMAS (US) | 2012-08-16 | — | — | US | disclosed |
| US-20120076848-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2012-03-29 | — | — | US | disclosed |
| US-20110280909-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-11-17 | — | — | US | disclosed |
| WO-2011011065-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-01-27 | — | — | WO | disclosed |
| WO-2010087983-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2010-08-05 | — | — | WO | disclosed |
| US-6737439-B2 | ACTIVE CANCER CHEMOPREVENTATIVE AND TREATING AGENTS IN MAMMALS, INCLUDING HUMANS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2004-05-18 | — | — | US | disclosed |
| US-20030125377-A1 | Aromatase inhibitors from Broussonetia papyrifera | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS THE | 2003-07-03 | — | — | US | disclosed |
| WO-2003013554-A2 | AROMATASE INHIBITORS FROM BROUSSONETIA PAPYRIFERA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125377-A1 | Aromatase inhibitors from Broussonetia papyrifera | CYP19A1, HSD17B11, CYP17A1 | CYP19A1 1/4885PTGS1 35/4885PTGS2 65/4885 |
| US-20140018552-A1 | USE OF COMPOUNDS ISOLATED FROM MORUS BARK | AGER, MORF4L1, HNRNPF | CYP19A1 4159/4885PTGS1 267/4885PTGS2 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.